EHR data support reported effectiveness of Ad26.COV2.S vaccine – Medical Xpress

The effectiveness of the Johnson & Johnson Ad26.COV2.S vaccine is 73.6 percent for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online Nov. 2 in JAMA Network Open.
Juan Corchado-Garcia,…

Click here to view the original article.